SlideShare a Scribd company logo
1 of 6
SkinCancer
W3 L1 & 5
Skin Cancer
Malignant Melanoma
- Nowthe most commoncancer in15-24 yearolds
- Twice as manyyoungwomengetmelanomabutmore mendie
- FastestincreasingcancerinScotland. More commonin females(2:1)
- Ugly ducklingsign –one mole outof manyis differentcolourandshape
- Can arise at any site butmostcommon onsun exposedsites –scalp,face,neck,arm, trunk,leg
- Rarelyoccur ineye,meninges,oesophagus,biliarytract,anus– cellsgettrappedin
embryogenesis
BreslowThickness – the depthfromthe granularlayerof the epidermistothe deepestmelanoma
cell.Itis usedasa prognosticindicatorof skincancer.
- BreslowThickness < 1 mm 5 yearsurvival is95-100%
- BreslowThickness 1-2mm 80%
- BreslowThickness > 4 mm 50%
- Metastases 5%
- Thinmelanomasare cured.Earlydiagnosisisessential.
A – asymmetry
B – border
C – colour– lightbrownisacceptable,anyothercolourisnot (pinkblue andwhite are the worst
colours).Irregularpigmentation.
D – diameter– upto 6mm isok
E – evolution –change?Pain?Bleeding?Oozing? Satellite nodules?Ulceration?
Otheradverse prognosticindicators
• Ulcerationisa strong adverse indicator
• Suffix bindicatestumourulceratione.g.pT3bisa tumourbetween2-4mmwithulceration –
ulcerationjumpsupa stage and survival rate decreases. a = notulcerated(e.g.pT1a)
• Highmitoticrate,lymphovascularinvasion,satellites,sentinellymphnode involvement
• Satellite depositsof melanomainskin=advancedmetastatic disease –verydifficulttomanage,
palliativecare
Four maintypesof melanoma:
• Superficial spreading (SSM) –trunksof menand legsof womenare the most commonareas.
Most commonsubtype,affectsyoung/middleagedadults. Usuallymaculewithirregularborder
and colourwhichmayhave beenincreasinginsize foryears(slow horizontal growthphase)
before developinganodule (rapidvertical growthphase).
• Acral/mucosal lentiginous-acral andmucosal (A/MLM) – palms,soles,nails andmucosal sites.
Usually inelderlypatients.Hutchinsonsign –pigmentedextensionintothe nail fold
• Lentigomaligna-sun-damagedface/neck/scalp (LMM) – elderlyface usually.Neoplastic
melanocytesalongthe basal layerwhichmaythenbecome invasive
• Nodular- variedsitesbutoftentrunk
• Notmain subtype - Amelanocyticmelanoma–Absentorminimal visible pigment.Rare.
SkinCancer
W3 L1 & 5
SSM, A/MLM and LMM:
- Grow as maculeswheneitherin-ituorwithdermal microinvasion(radialgrowthphase)
- Eventuallythe melanomacellsinvade the dermisforminganexpansile masswithmitoses
(vertical growthphase)
- Onlymelanomaswithavertical growthphase canmetastasise
Nodularmelanoma:
- No clinical ormicroscopicevidence of RGP
- A nodule of VGPtumour
- Some considerthismore aggressive
- Occurs at any bodysite
- Usuallyinolderpatients
- Blue-blackorred-skin-colourednodule whichmaybe ulceratedorbleedingandhasusually
developedrapidlyoverprecedingmonths
- Unlike nodulesdevelopinginsuperficial spreadingmelanoma,nodularmelanomasdonot
have any significantsurroundingmacularpigmentation
MM spread
- Local dermal lymphatics satellite depositsof MM – verybad prognosticsign
- Regional lymphnode metastases –commonpatternof disease progression. Nodesexcised
(radical lymphadenectomy)
- Bloodspread - Skin/ softtissue,Heart, Lungs,GI tract, liver,brain
MM treatment:
• Primaryexcisiontogive clearmargins
• Narrowcomplete excisionforconfirmationof diagnosisandassessmentof Breslow
• If in-situthenclearbycirca 5mm
• If invasive but<1mm thick -1cm clearance
• If invasive and>1mm thick -2cm clearance
• SNB if >1mm thickor thinnerwithmitoses
• Some alsoreceive asentinel nodebiopsy
• Sentinel lymphnode biopsycanprovide furtherprognosticinformation. If SN positive-
regional lymphadenectomy
• Treatmentof advanceddisease difficult
• Chemo,immunotherapy,genetictherapies
Melanomagenetics
Some acral melanomashave c-kitmutationsandmaybe treatedwithimantinib
Melanomasonintermittentlysun-exposedskinmayhave BRAFmutation
- Wildtype BRAFis a weakcytosolicproto-oncogene
- If mutateddrivescell proliferationbyup-regulatingMEKand ERK
- Range of drugsdevelopedtointerferewiththispathwaye.g.dabrafenibandvemurafenib
- Response timesare limited(onlyworksforabout6 months)
- May be betterincombinationwithMEKinhibitor
- May be betterinadjuvantsettingforhighrisklesionsbefore metastasesdevelop
- Rapidlyevolvingarea
SkinCancer
W3 L1 & 5
Non-melanoma skin cancer – Basal cell and squamous cell
• 90-95% of skincancers & Commonesthumancancer
• >100,000 cases peryearin UK & ~500 deaths/year
Basal Cell Carcinoma (BCC)
Clinical Presentation
- ~ 75% of NMSCs;verycommon – increasinglyseenin
youngerpatients
- Basal cellssproutfromepidermisandgroupsof cells
invade/budintodermis
- Mitosesandapoptosisverynumerous
- slowgrowinglumpornon-healingulcer–nodular,
superficial or ulcerated/infiltrative BCC
- painlessandoftenignored
- ‘pearly’ortranslucentbutcan be pigmentedBCC
- visible,arborisingbloodvessels
- central ulceration - “rodentulcer”
- can presentasscaly plaque - ‘superficial BCC’
- can be infiltrative- ‘morphoeicBCC’ – tumourcellsdosubclinical therefore are hardtotreat
- locallyinvasive,butrarelymetastasize40 yrs,but can be 3rd or 4th decade
- Margins are poorlydefinedandmayspreadalongnerves
- Can damage bonesof face or eyesif too close – resectionischallenging
- May kill byinvadingeye  brain–veryhard to treat/cure
Squamous Cell Carcinoma
Clinical Presentation
- about20% of all skincancers
- hyperkeratotic(crusted) orwarty lumpor non-
healingulcer
- arisesonsun-damagedskin
- grow relativelyfast,maybe painful &/orbleed
– feel lumptodiagnose
- majority- well differentiatedlowriskSCC –best
prognosis
- minority - poorlydifferentiatedhighriskSCC –
worstprognosis
- Ear, face,lipand scalpare highrisksites
- Perineural spreadisanadverse prognostic
indicator
- Precursors:Bowen’sdisease (esp.onlegs),
Actinickeratosis(esp.onhead/neck),Viral lesions(esp.onanogenitalskin).These precursorsshow
squamousdysplasia
- NotuncommoninUK forSCC to grow onchronic ulcers/scars/wounds
- Rare associationswith xerodermapigmentosumanddystrophicvariantepidermolysisbullosa
SkinCancer
W3 L1 & 5
- riskof metastasisabout5% - seriousconsequences
- poor prognosisonce metastatic
- Keratoacanthoma(KA) - self-resolving(notmalignantbutlookslikeSCC – remove tobe sure)
- 50% furtherNMSCat 5 years
- 5 yearsurvival rate of metastaticSCC25%
Actinickeratoses–pre-cancerousskinlesions,highlyassociatedwithincreasedriskof SCCor BCC.
Oftenmultiplegiving“fielddamage”ormore severe “fieldcancerisation”.
Potentially pre-malignant cutaneous tumours:
Actinickeratosis:
- Developlaterinlife inwhite-skinnedpeoplewhohave hadsignificantsunexposure
- Appearonsun exposedareas
- Erythematoussilver-scalypapulesorpatcheswithaconical surface and redbase
- Backgroundskin isofteninelastic,wrinkledandmayshow flatbrownmacules(solar
lentigos) reflectingdiffuse solardamage
- Small proportioncantransforminSCC but onlyaftermanyyears
- Tx – cryotherapy,topical 5-fluoroacill cream, 5% imiquimodcreamordiclofenacgel
Bowen’sdisease
- Intraepidermalcarcinomain-situ
- Rarelybecomesinvasive
- Due to longterm sunexposure andpresentsonsunexposedareas,mostcommonly
womenslegs
- No maturationof cellsleadstoparakeratosisonsurface
- Isolatedscalyredpatchor plaque lookinglike psoriasisbutithas an irregularedge
- Slowlyincrease withtimebutnodermal invasion
- Tx – cryotherapy,topical 5-fluoroacill cream, 5% imiquimodcream, cryotherapy,curettage
Actinickeratosis
- Verycommon
- Sun-exposedskinesp.scalp,face,hands
- Variable epidermal dysplasia
- Severelyatypical lesionsare bowenoid(lookslike
bowensdisease)
- Commonprecursorof invasive SCC
Atypical/Dysplasticnaevussyndrome –see W3 L3&4 notes
Giant congenital melanocyticnaevi - see W3L3&4 notes
Viral precursors
- Viral genital lesionsoftendysplastic withelevatedatypical mitoses
- Erythroplasiaof Queryat= penile Bowen’s
- AssociatedwithHumanpapillomavirus - HPVtype 16 associatedwithdysplasia
- HPV in almost100% penile dysplasia.HPV foundin50% invasive penileSCC
SkinCancer
W3 L1 & 5
Risk factors for skin cancer
- Sunexposure (espUVA)
o Sunburnandsolar lentigo(liverspots,oldage spots) reflectUVBdamage,whereassolarageing
isattributedtothe deeperpenetrationandsolar elastosisof UVA.
o The formationof ‘sunburn’cellsisaprotective mechanismwherebybadlyUV-damaged
keratinocytesundergoapoptosisorprogrammedcell death.Frecklesoccurinthose who
cannot tan sufficientlytoprotecttheirskinfromsun.
o Damage occurs repeatedlyleadingtoDNA mutationsandskincanceroccurs
o Up to 80% sun damage occurs duringfirst18 years
o Childhoodsunburnincreasesmelanomarisk4x
o SCC - chronic,cumulative UV-exposure(total exposureisthe mostimportantfactor,
irrespectiveof howitisachieved)
o BCC - intermittent,intensesunburnepisodes
o Melanoma- intermittent,intensesunburnepisodes
o Those whowork outdoors(farmers,sailorsetc) are at increasedriskastheyare constantly
exposingtheirbodiestothe sun.
- Geneticsusceptibility
o Amountandtype of melanindictatesyouskintype (SPT1-4)
o DNA repairsyndromes,e.g.XerodermaPigmentosum –defectinone of 7 nucleotide
excisionrepairgenesleadingtophotosensitivity,skincancersonUV-exposedsites,
neurological degenerationandincreasedriskof othercancers
o Albinism
o Naevoidbasal cell carcinoma(Gorlin’s) syndrome –autosomadominantfamilial cancer
syndrome – earlyonset/multiple BCCs.Palmerpitsjaw cystsandectopiccalcificationfalx
- Immunosuppression –SCC isthe most commonformof skincancerin these patients.Organ
transplantrecipientsneedregularskinsurveillance.
- Otherenvironmental carcinogens:coal tar,smoking,ionisingradiation,arsenic,trauma,chronic
ulceration
Phototoxic drugs:
- Voriconazole Thiazide diuretics
- Anti-TNF NSAIDs
- BRAFinhibitors
Skin cancer prevention
Behaviour:
- avoidsunat its height(11am-3pm)
- use shade whereverpossible
- particularcare of babies/children
avoidsunbeds
Sunscreens- broadspectrum(SPF25+)
withUVA protection
Clothing
- tightlywoven,loose fittingclothing
(dark)
- longsleeves,trousers,skirts
Regular (self-) surveillance
Examine molesregularlyandif in
doubt“check itout”
Sun Smart
S – Stay inthe shade 11am-3pm
M – Make sure youneverburn
A – Alwayscoverup
R – Remembertotake extracare with
children
T – Thenuse factor 15+ sunscreen
SkinCancer
W3 L1 & 5

More Related Content

What's hot

Ureteric injury
Ureteric injuryUreteric injury
Ureteric injurySagnik24
 
Trocar/Port Placement for the Procedure: General Strategies
Trocar/Port Placement for the Procedure: General StrategiesTrocar/Port Placement for the Procedure: General Strategies
Trocar/Port Placement for the Procedure: General StrategiesGeorge S. Ferzli
 
Whipple complication
Whipple complicationWhipple complication
Whipple complicationAnil Kumar
 
What is New In Minimally Invasive Surgery for Urology
What is New In Minimally Invasive Surgery for UrologyWhat is New In Minimally Invasive Surgery for Urology
What is New In Minimally Invasive Surgery for UrologySiewhong Ho
 
Ureteric injury ppt Dr. Neha Jain, JNMCH, AMU, Aligarh
Ureteric injury ppt Dr. Neha Jain, JNMCH, AMU, AligarhUreteric injury ppt Dr. Neha Jain, JNMCH, AMU, Aligarh
Ureteric injury ppt Dr. Neha Jain, JNMCH, AMU, AligarhNeha Jain
 
Essentials of lap
Essentials of lapEssentials of lap
Essentials of lapHome
 
Urinary Diversion after cystectomy [Dr.Edmond Wong]
Urinary Diversion after cystectomy  [Dr.Edmond Wong]Urinary Diversion after cystectomy  [Dr.Edmond Wong]
Urinary Diversion after cystectomy [Dr.Edmond Wong]Edmond Wong
 
Abdominoperineal resection.pptx
Abdominoperineal resection.pptxAbdominoperineal resection.pptx
Abdominoperineal resection.pptxmasoom parwez
 
Rectal prolapse.pptx
Rectal prolapse.pptxRectal prolapse.pptx
Rectal prolapse.pptxPradeep Pande
 
Carcinoma anal canal.pptx
Carcinoma anal canal.pptxCarcinoma anal canal.pptx
Carcinoma anal canal.pptxPradeep Pande
 
Types of Suture material
Types of  Suture material Types of  Suture material
Types of Suture material Hiren Patoliya
 

What's hot (20)

Ureteric injury
Ureteric injuryUreteric injury
Ureteric injury
 
FUTURE OF LAPAROSCOPY
FUTURE OF LAPAROSCOPYFUTURE OF LAPAROSCOPY
FUTURE OF LAPAROSCOPY
 
Rectal Prolapse
Rectal ProlapseRectal Prolapse
Rectal Prolapse
 
Colorectal polyp
Colorectal  polypColorectal  polyp
Colorectal polyp
 
Trocar/Port Placement for the Procedure: General Strategies
Trocar/Port Placement for the Procedure: General StrategiesTrocar/Port Placement for the Procedure: General Strategies
Trocar/Port Placement for the Procedure: General Strategies
 
Whipple complication
Whipple complicationWhipple complication
Whipple complication
 
Sutures Knots
Sutures KnotsSutures Knots
Sutures Knots
 
What is New In Minimally Invasive Surgery for Urology
What is New In Minimally Invasive Surgery for UrologyWhat is New In Minimally Invasive Surgery for Urology
What is New In Minimally Invasive Surgery for Urology
 
Laparoscopic Cholecystectomy
Laparoscopic CholecystectomyLaparoscopic Cholecystectomy
Laparoscopic Cholecystectomy
 
Ureteric injury ppt Dr. Neha Jain, JNMCH, AMU, Aligarh
Ureteric injury ppt Dr. Neha Jain, JNMCH, AMU, AligarhUreteric injury ppt Dr. Neha Jain, JNMCH, AMU, Aligarh
Ureteric injury ppt Dr. Neha Jain, JNMCH, AMU, Aligarh
 
Essentials of lap
Essentials of lapEssentials of lap
Essentials of lap
 
Urinary Diversion after cystectomy [Dr.Edmond Wong]
Urinary Diversion after cystectomy  [Dr.Edmond Wong]Urinary Diversion after cystectomy  [Dr.Edmond Wong]
Urinary Diversion after cystectomy [Dr.Edmond Wong]
 
Lipoma and liposarcoma
Lipoma and liposarcoma Lipoma and liposarcoma
Lipoma and liposarcoma
 
Orchiectomy
OrchiectomyOrchiectomy
Orchiectomy
 
Seroma presentation
Seroma presentationSeroma presentation
Seroma presentation
 
Abdominoperineal resection.pptx
Abdominoperineal resection.pptxAbdominoperineal resection.pptx
Abdominoperineal resection.pptx
 
Rectal prolapse.pptx
Rectal prolapse.pptxRectal prolapse.pptx
Rectal prolapse.pptx
 
Carcinoma anal canal.pptx
Carcinoma anal canal.pptxCarcinoma anal canal.pptx
Carcinoma anal canal.pptx
 
Orthotopic neobladder
Orthotopic neobladderOrthotopic neobladder
Orthotopic neobladder
 
Types of Suture material
Types of  Suture material Types of  Suture material
Types of Suture material
 

Similar to Skin Cancer

Cutaneous malignancies
Cutaneous malignanciesCutaneous malignancies
Cutaneous malignanciesharish kabilan
 
TUMOURS OF EYELID AND ORBIT.pptx
TUMOURS OF EYELID AND ORBIT.pptxTUMOURS OF EYELID AND ORBIT.pptx
TUMOURS OF EYELID AND ORBIT.pptxRojitaBajracharya3
 
Review course in ocular oncology
Review course in ocular oncologyReview course in ocular oncology
Review course in ocular oncologyHatem Krema
 
MALIGNANT MELANOMA.pdf
MALIGNANT MELANOMA.pdfMALIGNANT MELANOMA.pdf
MALIGNANT MELANOMA.pdfShapi. MD
 
melanoma (2).pptx
melanoma (2).pptxmelanoma (2).pptx
melanoma (2).pptxAl Mamun
 
Breast carcinoma pathology
Breast carcinoma pathologyBreast carcinoma pathology
Breast carcinoma pathologyKripa Vijay
 
Melanoma update 2019- Dr Anand Bhandary Panambur
Melanoma update 2019- Dr Anand Bhandary PanamburMelanoma update 2019- Dr Anand Bhandary Panambur
Melanoma update 2019- Dr Anand Bhandary PanamburAnandBhandary
 
malignant skin lesions /BASIC MEDICAL KNWOLEDGE .ppt
malignant skin lesions /BASIC MEDICAL KNWOLEDGE .pptmalignant skin lesions /BASIC MEDICAL KNWOLEDGE .ppt
malignant skin lesions /BASIC MEDICAL KNWOLEDGE .pptMUJEEB REHMAN
 
Squamous cell carcinoma, Basal cell carcinoma, Sebaceous gland carcinoma
Squamous cell carcinoma, Basal cell carcinoma, Sebaceous gland carcinomaSquamous cell carcinoma, Basal cell carcinoma, Sebaceous gland carcinoma
Squamous cell carcinoma, Basal cell carcinoma, Sebaceous gland carcinomaAniah Azmi
 
Benign skin lesions_091820.pptx
Benign skin lesions_091820.pptxBenign skin lesions_091820.pptx
Benign skin lesions_091820.pptxdrazizsaleh94
 
01. Skin Cancers. Malignant Melanoma_46b2a6038a76b84424cf26728d1df7bd.pdf
01. Skin Cancers. Malignant Melanoma_46b2a6038a76b84424cf26728d1df7bd.pdf01. Skin Cancers. Malignant Melanoma_46b2a6038a76b84424cf26728d1df7bd.pdf
01. Skin Cancers. Malignant Melanoma_46b2a6038a76b84424cf26728d1df7bd.pdfOghenemesaOnobiokor
 

Similar to Skin Cancer (20)

Skin Cancer
Skin CancerSkin Cancer
Skin Cancer
 
Cutaneous malignancies
Cutaneous malignanciesCutaneous malignancies
Cutaneous malignancies
 
Malignant Melanoma
Malignant MelanomaMalignant Melanoma
Malignant Melanoma
 
TUMOURS OF EYELID AND ORBIT.pptx
TUMOURS OF EYELID AND ORBIT.pptxTUMOURS OF EYELID AND ORBIT.pptx
TUMOURS OF EYELID AND ORBIT.pptx
 
Malignant melanoma
Malignant melanomaMalignant melanoma
Malignant melanoma
 
Review course in ocular oncology
Review course in ocular oncologyReview course in ocular oncology
Review course in ocular oncology
 
MALIGNANT MELANOMA.pdf
MALIGNANT MELANOMA.pdfMALIGNANT MELANOMA.pdf
MALIGNANT MELANOMA.pdf
 
melanoma (2).pptx
melanoma (2).pptxmelanoma (2).pptx
melanoma (2).pptx
 
Tumors of the eye
Tumors of the eyeTumors of the eye
Tumors of the eye
 
Bcc &amp; s cc
Bcc &amp; s ccBcc &amp; s cc
Bcc &amp; s cc
 
Breast carcinoma pathology
Breast carcinoma pathologyBreast carcinoma pathology
Breast carcinoma pathology
 
Seminar ca penis
Seminar ca penisSeminar ca penis
Seminar ca penis
 
Melanoma update 2019- Dr Anand Bhandary Panambur
Melanoma update 2019- Dr Anand Bhandary PanamburMelanoma update 2019- Dr Anand Bhandary Panambur
Melanoma update 2019- Dr Anand Bhandary Panambur
 
malignant skin lesions /BASIC MEDICAL KNWOLEDGE .ppt
malignant skin lesions /BASIC MEDICAL KNWOLEDGE .pptmalignant skin lesions /BASIC MEDICAL KNWOLEDGE .ppt
malignant skin lesions /BASIC MEDICAL KNWOLEDGE .ppt
 
Malignant melanoma A-Z
Malignant melanoma A-ZMalignant melanoma A-Z
Malignant melanoma A-Z
 
Parotid
ParotidParotid
Parotid
 
Squamous cell carcinoma, Basal cell carcinoma, Sebaceous gland carcinoma
Squamous cell carcinoma, Basal cell carcinoma, Sebaceous gland carcinomaSquamous cell carcinoma, Basal cell carcinoma, Sebaceous gland carcinoma
Squamous cell carcinoma, Basal cell carcinoma, Sebaceous gland carcinoma
 
Benign skin lesions_091820.pptx
Benign skin lesions_091820.pptxBenign skin lesions_091820.pptx
Benign skin lesions_091820.pptx
 
Malignant eyelid tumours
Malignant eyelid tumoursMalignant eyelid tumours
Malignant eyelid tumours
 
01. Skin Cancers. Malignant Melanoma_46b2a6038a76b84424cf26728d1df7bd.pdf
01. Skin Cancers. Malignant Melanoma_46b2a6038a76b84424cf26728d1df7bd.pdf01. Skin Cancers. Malignant Melanoma_46b2a6038a76b84424cf26728d1df7bd.pdf
01. Skin Cancers. Malignant Melanoma_46b2a6038a76b84424cf26728d1df7bd.pdf
 

More from meducationdotnet

More from meducationdotnet (20)

No Title
No TitleNo Title
No Title
 
Spondylarthropathy
SpondylarthropathySpondylarthropathy
Spondylarthropathy
 
Diagnosing Lung cancer
Diagnosing Lung cancerDiagnosing Lung cancer
Diagnosing Lung cancer
 
Eczema Herpeticum
Eczema HerpeticumEczema Herpeticum
Eczema Herpeticum
 
The Vagus Nerve
The Vagus NerveThe Vagus Nerve
The Vagus Nerve
 
Water and sanitation and their impact on health
Water and sanitation and their impact on healthWater and sanitation and their impact on health
Water and sanitation and their impact on health
 
The ethics of electives
The ethics of electivesThe ethics of electives
The ethics of electives
 
Intro to Global Health
Intro to Global HealthIntro to Global Health
Intro to Global Health
 
WTO and Health
WTO and HealthWTO and Health
WTO and Health
 
Globalisation and Health
Globalisation and HealthGlobalisation and Health
Globalisation and Health
 
Health Care Worker Migration
Health Care Worker MigrationHealth Care Worker Migration
Health Care Worker Migration
 
International Institutions
International InstitutionsInternational Institutions
International Institutions
 
Haemochromotosis brief overview
Haemochromotosis brief overviewHaemochromotosis brief overview
Haemochromotosis brief overview
 
Ascities overview
Ascities overviewAscities overview
Ascities overview
 
Overview of the Liver
Overview of the LiverOverview of the Liver
Overview of the Liver
 
Overview of Antidepressants
Overview of AntidepressantsOverview of Antidepressants
Overview of Antidepressants
 
Gout Presentation
Gout PresentationGout Presentation
Gout Presentation
 
Review of orthopaedic services: Prepared for the Auditor General for Scotland...
Review of orthopaedic services: Prepared for the Auditor General for Scotland...Review of orthopaedic services: Prepared for the Auditor General for Scotland...
Review of orthopaedic services: Prepared for the Auditor General for Scotland...
 
Sugammadex - a revolution in anaesthesia?
Sugammadex - a revolution in anaesthesia?Sugammadex - a revolution in anaesthesia?
Sugammadex - a revolution in anaesthesia?
 
Ophthamology Revision
Ophthamology RevisionOphthamology Revision
Ophthamology Revision
 

Skin Cancer

  • 1. SkinCancer W3 L1 & 5 Skin Cancer Malignant Melanoma - Nowthe most commoncancer in15-24 yearolds - Twice as manyyoungwomengetmelanomabutmore mendie - FastestincreasingcancerinScotland. More commonin females(2:1) - Ugly ducklingsign –one mole outof manyis differentcolourandshape - Can arise at any site butmostcommon onsun exposedsites –scalp,face,neck,arm, trunk,leg - Rarelyoccur ineye,meninges,oesophagus,biliarytract,anus– cellsgettrappedin embryogenesis BreslowThickness – the depthfromthe granularlayerof the epidermistothe deepestmelanoma cell.Itis usedasa prognosticindicatorof skincancer. - BreslowThickness < 1 mm 5 yearsurvival is95-100% - BreslowThickness 1-2mm 80% - BreslowThickness > 4 mm 50% - Metastases 5% - Thinmelanomasare cured.Earlydiagnosisisessential. A – asymmetry B – border C – colour– lightbrownisacceptable,anyothercolourisnot (pinkblue andwhite are the worst colours).Irregularpigmentation. D – diameter– upto 6mm isok E – evolution –change?Pain?Bleeding?Oozing? Satellite nodules?Ulceration? Otheradverse prognosticindicators • Ulcerationisa strong adverse indicator • Suffix bindicatestumourulceratione.g.pT3bisa tumourbetween2-4mmwithulceration – ulcerationjumpsupa stage and survival rate decreases. a = notulcerated(e.g.pT1a) • Highmitoticrate,lymphovascularinvasion,satellites,sentinellymphnode involvement • Satellite depositsof melanomainskin=advancedmetastatic disease –verydifficulttomanage, palliativecare Four maintypesof melanoma: • Superficial spreading (SSM) –trunksof menand legsof womenare the most commonareas. Most commonsubtype,affectsyoung/middleagedadults. Usuallymaculewithirregularborder and colourwhichmayhave beenincreasinginsize foryears(slow horizontal growthphase) before developinganodule (rapidvertical growthphase). • Acral/mucosal lentiginous-acral andmucosal (A/MLM) – palms,soles,nails andmucosal sites. Usually inelderlypatients.Hutchinsonsign –pigmentedextensionintothe nail fold • Lentigomaligna-sun-damagedface/neck/scalp (LMM) – elderlyface usually.Neoplastic melanocytesalongthe basal layerwhichmaythenbecome invasive • Nodular- variedsitesbutoftentrunk • Notmain subtype - Amelanocyticmelanoma–Absentorminimal visible pigment.Rare.
  • 2. SkinCancer W3 L1 & 5 SSM, A/MLM and LMM: - Grow as maculeswheneitherin-ituorwithdermal microinvasion(radialgrowthphase) - Eventuallythe melanomacellsinvade the dermisforminganexpansile masswithmitoses (vertical growthphase) - Onlymelanomaswithavertical growthphase canmetastasise Nodularmelanoma: - No clinical ormicroscopicevidence of RGP - A nodule of VGPtumour - Some considerthismore aggressive - Occurs at any bodysite - Usuallyinolderpatients - Blue-blackorred-skin-colourednodule whichmaybe ulceratedorbleedingandhasusually developedrapidlyoverprecedingmonths - Unlike nodulesdevelopinginsuperficial spreadingmelanoma,nodularmelanomasdonot have any significantsurroundingmacularpigmentation MM spread - Local dermal lymphatics satellite depositsof MM – verybad prognosticsign - Regional lymphnode metastases –commonpatternof disease progression. Nodesexcised (radical lymphadenectomy) - Bloodspread - Skin/ softtissue,Heart, Lungs,GI tract, liver,brain MM treatment: • Primaryexcisiontogive clearmargins • Narrowcomplete excisionforconfirmationof diagnosisandassessmentof Breslow • If in-situthenclearbycirca 5mm • If invasive but<1mm thick -1cm clearance • If invasive and>1mm thick -2cm clearance • SNB if >1mm thickor thinnerwithmitoses • Some alsoreceive asentinel nodebiopsy • Sentinel lymphnode biopsycanprovide furtherprognosticinformation. If SN positive- regional lymphadenectomy • Treatmentof advanceddisease difficult • Chemo,immunotherapy,genetictherapies Melanomagenetics Some acral melanomashave c-kitmutationsandmaybe treatedwithimantinib Melanomasonintermittentlysun-exposedskinmayhave BRAFmutation - Wildtype BRAFis a weakcytosolicproto-oncogene - If mutateddrivescell proliferationbyup-regulatingMEKand ERK - Range of drugsdevelopedtointerferewiththispathwaye.g.dabrafenibandvemurafenib - Response timesare limited(onlyworksforabout6 months) - May be betterincombinationwithMEKinhibitor - May be betterinadjuvantsettingforhighrisklesionsbefore metastasesdevelop - Rapidlyevolvingarea
  • 3. SkinCancer W3 L1 & 5 Non-melanoma skin cancer – Basal cell and squamous cell • 90-95% of skincancers & Commonesthumancancer • >100,000 cases peryearin UK & ~500 deaths/year Basal Cell Carcinoma (BCC) Clinical Presentation - ~ 75% of NMSCs;verycommon – increasinglyseenin youngerpatients - Basal cellssproutfromepidermisandgroupsof cells invade/budintodermis - Mitosesandapoptosisverynumerous - slowgrowinglumpornon-healingulcer–nodular, superficial or ulcerated/infiltrative BCC - painlessandoftenignored - ‘pearly’ortranslucentbutcan be pigmentedBCC - visible,arborisingbloodvessels - central ulceration - “rodentulcer” - can presentasscaly plaque - ‘superficial BCC’ - can be infiltrative- ‘morphoeicBCC’ – tumourcellsdosubclinical therefore are hardtotreat - locallyinvasive,butrarelymetastasize40 yrs,but can be 3rd or 4th decade - Margins are poorlydefinedandmayspreadalongnerves - Can damage bonesof face or eyesif too close – resectionischallenging - May kill byinvadingeye  brain–veryhard to treat/cure Squamous Cell Carcinoma Clinical Presentation - about20% of all skincancers - hyperkeratotic(crusted) orwarty lumpor non- healingulcer - arisesonsun-damagedskin - grow relativelyfast,maybe painful &/orbleed – feel lumptodiagnose - majority- well differentiatedlowriskSCC –best prognosis - minority - poorlydifferentiatedhighriskSCC – worstprognosis - Ear, face,lipand scalpare highrisksites - Perineural spreadisanadverse prognostic indicator - Precursors:Bowen’sdisease (esp.onlegs), Actinickeratosis(esp.onhead/neck),Viral lesions(esp.onanogenitalskin).These precursorsshow squamousdysplasia - NotuncommoninUK forSCC to grow onchronic ulcers/scars/wounds - Rare associationswith xerodermapigmentosumanddystrophicvariantepidermolysisbullosa
  • 4. SkinCancer W3 L1 & 5 - riskof metastasisabout5% - seriousconsequences - poor prognosisonce metastatic - Keratoacanthoma(KA) - self-resolving(notmalignantbutlookslikeSCC – remove tobe sure) - 50% furtherNMSCat 5 years - 5 yearsurvival rate of metastaticSCC25% Actinickeratoses–pre-cancerousskinlesions,highlyassociatedwithincreasedriskof SCCor BCC. Oftenmultiplegiving“fielddamage”ormore severe “fieldcancerisation”. Potentially pre-malignant cutaneous tumours: Actinickeratosis: - Developlaterinlife inwhite-skinnedpeoplewhohave hadsignificantsunexposure - Appearonsun exposedareas - Erythematoussilver-scalypapulesorpatcheswithaconical surface and redbase - Backgroundskin isofteninelastic,wrinkledandmayshow flatbrownmacules(solar lentigos) reflectingdiffuse solardamage - Small proportioncantransforminSCC but onlyaftermanyyears - Tx – cryotherapy,topical 5-fluoroacill cream, 5% imiquimodcreamordiclofenacgel Bowen’sdisease - Intraepidermalcarcinomain-situ - Rarelybecomesinvasive - Due to longterm sunexposure andpresentsonsunexposedareas,mostcommonly womenslegs - No maturationof cellsleadstoparakeratosisonsurface - Isolatedscalyredpatchor plaque lookinglike psoriasisbutithas an irregularedge - Slowlyincrease withtimebutnodermal invasion - Tx – cryotherapy,topical 5-fluoroacill cream, 5% imiquimodcream, cryotherapy,curettage Actinickeratosis - Verycommon - Sun-exposedskinesp.scalp,face,hands - Variable epidermal dysplasia - Severelyatypical lesionsare bowenoid(lookslike bowensdisease) - Commonprecursorof invasive SCC Atypical/Dysplasticnaevussyndrome –see W3 L3&4 notes Giant congenital melanocyticnaevi - see W3L3&4 notes Viral precursors - Viral genital lesionsoftendysplastic withelevatedatypical mitoses - Erythroplasiaof Queryat= penile Bowen’s - AssociatedwithHumanpapillomavirus - HPVtype 16 associatedwithdysplasia - HPV in almost100% penile dysplasia.HPV foundin50% invasive penileSCC
  • 5. SkinCancer W3 L1 & 5 Risk factors for skin cancer - Sunexposure (espUVA) o Sunburnandsolar lentigo(liverspots,oldage spots) reflectUVBdamage,whereassolarageing isattributedtothe deeperpenetrationandsolar elastosisof UVA. o The formationof ‘sunburn’cellsisaprotective mechanismwherebybadlyUV-damaged keratinocytesundergoapoptosisorprogrammedcell death.Frecklesoccurinthose who cannot tan sufficientlytoprotecttheirskinfromsun. o Damage occurs repeatedlyleadingtoDNA mutationsandskincanceroccurs o Up to 80% sun damage occurs duringfirst18 years o Childhoodsunburnincreasesmelanomarisk4x o SCC - chronic,cumulative UV-exposure(total exposureisthe mostimportantfactor, irrespectiveof howitisachieved) o BCC - intermittent,intensesunburnepisodes o Melanoma- intermittent,intensesunburnepisodes o Those whowork outdoors(farmers,sailorsetc) are at increasedriskastheyare constantly exposingtheirbodiestothe sun. - Geneticsusceptibility o Amountandtype of melanindictatesyouskintype (SPT1-4) o DNA repairsyndromes,e.g.XerodermaPigmentosum –defectinone of 7 nucleotide excisionrepairgenesleadingtophotosensitivity,skincancersonUV-exposedsites, neurological degenerationandincreasedriskof othercancers o Albinism o Naevoidbasal cell carcinoma(Gorlin’s) syndrome –autosomadominantfamilial cancer syndrome – earlyonset/multiple BCCs.Palmerpitsjaw cystsandectopiccalcificationfalx - Immunosuppression –SCC isthe most commonformof skincancerin these patients.Organ transplantrecipientsneedregularskinsurveillance. - Otherenvironmental carcinogens:coal tar,smoking,ionisingradiation,arsenic,trauma,chronic ulceration Phototoxic drugs: - Voriconazole Thiazide diuretics - Anti-TNF NSAIDs - BRAFinhibitors Skin cancer prevention Behaviour: - avoidsunat its height(11am-3pm) - use shade whereverpossible - particularcare of babies/children avoidsunbeds Sunscreens- broadspectrum(SPF25+) withUVA protection Clothing - tightlywoven,loose fittingclothing (dark) - longsleeves,trousers,skirts Regular (self-) surveillance Examine molesregularlyandif in doubt“check itout” Sun Smart S – Stay inthe shade 11am-3pm M – Make sure youneverburn A – Alwayscoverup R – Remembertotake extracare with children T – Thenuse factor 15+ sunscreen